[28P1-am1] Chemical biology/Drug design/Synthetic compounds in drug discovery/Natural medicines and biological products/Structure-activity relationship/Others

[28P1-am1-105S] Substrate reactivity relationships of anti-SARS-CoV-2 compound N3 and development of PROTAC thereof

Mori Hosaka², Daichi Chida², ○Ryo Watanabe¹, Hiroyuki Yamakoshi^1,2, Takashi Toyama^1,2, Yoshiro Saito^1,2, Yoshiharu Iwabuchi^1,2 (1. Fac. Pharm. Sci., Tohoku Univ., 2. Grad. Sch. Pharm. Sci., Tohoku Univ.)